External Physical Vibration Lithecbole(EPVL) Versus Traditional Row of Stone After Retrograde Intrarenal Surgery(RIRS)

February 13, 2017 updated by: Guohua Zeng, The First Affiliated Hospital of Guangzhou Medical University

External Physical Vibration Lithecbole(EPVL) Contrast With the Traditional Row of Stone Effect After Retrograde Intrarenal Surgery(RIRS): A Multi-center Prospective Randomized Controlled Trial

The treatment of renal calculus by retrograde intrarenal surgery(RIRS) isn't able to eliminate stone completely, hastening fragments clearance just only rely on traditional expulsive methods such as high fluid intake ,increasing physical activity, medical expulsive therapy and changing body position. Therefore, researchers purpose to evaluate the effectiveness of external physical vibration lithecbole(EPVL) in treatment of residual fragments after RIRS by prospective study of clinical trial, which will improve stone-free rate of residual fragments and benefit more patients.

Study Overview

Detailed Description

To evaluate the efficacy and safety of external physical vibration lithecbole for the treatment of residual stone after the operation of RIRS,thereby improving stone clearance rate. Investigators will do a multi-centers randomized controlled trial(RCT),and investigators plan to perform this study in 10 hospitals,which are the First Affiliated Hospital of Guangzhou Medical University of China, Department of Urology, The Second Affiliated Hospital of Zhengzhou University of China, Jiangsu Province Hospital, Hubei Province Hospital, Zhongshan Hospital, Tongji Hospital,Hubei provincial people's Hospital,Guilin 181 Hospital,the People' Hospital of Huzhou,The People' Hospital of Shaoyang.

Investigators plan to beginning their study August 2015 and end July 2016. One hundred and eighty patients with postoperative residual stone after RIRS will be enrolled in this study. By simple random sampling technique, all the patients will be assigned to the segment of natural stone row group or physical row of stone group, compared two groups of patients with stone clearance rate and complications, Investigators hope that through this test, improve stone clearance rate after RIRS.

The principle of extracorporeal physical vibration:

A Simple harmonic motion technology in multi-direction was applied. The Lateral acceleration was provided by the physical vibration device in the base through the harmonic vibration wave in the horizontal direction, which induces the urinary stone separate with the kidney or ureter, and expands a moving space for the stone. Meanwhile, an axial effect was produced to push the stone by the physical vibration device in the handle through the harmonic vibration wave in the multi- direction. Finally, with the help of changing the position and direction of the extracorporeally physical vibration machine, the urinary stone was discharged from the urinary collecting system.

Number:

180cases(90 cases in control group, 90 cases in EPVL group)

Grouping methods:

In this trial, investigators use equilibrium randomization methods that generate random numerical code table, according to the table, patients are randomly assigned to different groups.

Evaluating indicator Stone-free rate in 5 weeks after RIRS. Incidence rate of complications and adverse reactions after EPVL(fever, hematuria).

Trial method; Cases selection and grouping: in 1 week after RIRS, the imaging KUB(abdominal plain film), patients with radiolucent calculus need to be examined by CT demonstrate the presence of residual fragments, and the cases that meeting inclusion criterion are randomly assigned to groups, and the ureteral stent should be removed in 2 weeks;

Laboratory testing: blood routine, urine routine, renal function , coagulation function; Strat the treatment of EPVL before the removal of ureteral stent.

Methods of control group(group1):

RIRS without EPVL Patients should be reexamined respectively in 1 and 2 weeks after RIRS, and the ureteral stent should be removed in 2 weeks;

Patients should follow the measures below:

  1. the amount of fluid intake is more than 2000ml/d
  2. increase physical activity
  3. rest in position on uninjured side, patients with lower renal calyx calculus need to invert body;

Follow up timing: respectively in 2 ,3 and 5 weeks after RIRS.

Methods of EPVL group(group2):

Preparation before EPVL: the amount of fluid intake is about 1000-2000ml, start the treatment of EPVL when patient's bladder is filling;

Record: patients' information, outcome of treatment (examined by KUB right after EPVL); Start the treatment of EPVL;

Patients should follow the measures below:

  1. the amount of fluid intake is more than 2000ml/d
  2. increase physical activity
  3. rest in position on uninjured side, patients with lower renal calyx calculus need to invert body;

Patients should be reexamined in one week, meanwhile removing ureteral stent or perhaps undergoing the treatment of EPVL once again.

Follow up timing: respectively in 1,2 and 4 weeks after EPVL..

Follow up project Laboratory testing: routine urinalysis; Imaging examination: KUB or kidney CT scan (radiolucent calculus) Complications and adverse reactions. Data gathering Fill in follow up table data; Radiological images; IVP(intravenous pyelography) or kidney CT scan; Reexamined by KUB (radiopaque calculus) or CT (radiolucent calculus) right after RIRS, respectively in 2 ,3 and 5 weeks after RIRS. If stones have been eliminated completely in patients with radiolucent calculus before or at the fourth week of follow-up, investigator must provide kidney CT scan.

Study Type

Interventional

Enrollment (Anticipated)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510230
        • Recruiting
        • Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age of 18-65 years;
  2. The imaging demonstrate the presence of residual fragments in 1 week after RIRS;
  3. Renal or upper ureteral calculus;
  4. There's no urinary tract obstruction below stones, and stones didn't cause complete urinary tract obstruction;
  5. Stones are fragmented successfully on single session of RIRS, and the diameter of any of fragments is less than 4mm;
  6. Normal renal function.

Exclusion Criteria:

  1. Couldn't tolerate EPVL;
  2. Urinary tract anomalies, stricture or obstruction;
  3. Calculus in diverticulum;
  4. Severe hydronephrosis;
  5. Combined with acute urinary tract infection;
  6. Coagulation abnormalities;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Retrograde Intrarenal Surgery (RIRS)
Patients in Group 1 undergo Retrograde Intrarenal Surgery
Patients undergo Retrograde Intrarenal Surgery
Other: EPVL after RIRS

Patients in Group 2 undergo external physical vibration lithecbole after Retrograde Intrarenal Surgery.

with the help of changing the position and direction of the extracorporeally physical vibration machine, the urinary stone was discharged from the urinary collecting system

Patients in Group 2 undergo EPVL after RIRS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from stone free rate(SFR) with different follow-up periods
Time Frame: return hospital respectively in 2,3 and 5 week after RIRS
Primary SFR is assessed by abdominal plain film (KUB)at2,3,5 week after operation. Stone-free status are defined as either the absence of any residual stone fragments.
return hospital respectively in 2,3 and 5 week after RIRS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
extracorporeal physical vibration complications
Time Frame: return hospital respectively in 2 ,3 and 5 weeks after RIRS
Complication is defined as any adverse event occurred
return hospital respectively in 2 ,3 and 5 weeks after RIRS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Anticipated)

March 1, 2017

Study Completion (Anticipated)

March 1, 2017

Study Registration Dates

First Submitted

December 7, 2015

First Submitted That Met QC Criteria

January 1, 2016

First Posted (Estimate)

January 5, 2016

Study Record Updates

Last Update Posted (Actual)

February 15, 2017

Last Update Submitted That Met QC Criteria

February 13, 2017

Last Verified

August 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Calculi

Clinical Trials on Retrograde Intrarenal Surgery

3
Subscribe